Sunshine Biopharma Inc.
About Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $36.3M
- Net income
- -$6.0M
- Total assets
- $30.1M
- Market cap
- $4.0M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $4.0M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 9, 2007
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review Sunshine Biopharma Inc..
